These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31322990)

  • 41. Preferences of patients with advanced lung cancer regarding the involvement of family and others in medical decision-making.
    Pardon K; Deschepper R; Stichele RV; Bernheim JL; Mortier F; Bossuyt N; Schallier D; Germonpré P; Galdermans D; Van Kerckhoven W; Deliens L;
    J Palliat Med; 2010 Oct; 13(10):1199-203. PubMed ID: 20849278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lung cancer in Victoria: are we making progress?
    Mitchell PL; Thursfield VJ; Ball DL; Richardson GE; Irving LB; Torn-Broers Y; Giles GG; Wright GM
    Med J Aust; 2013 Nov; 199(10):674-9. PubMed ID: 24237097
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patients preferences in chemotherapy for advanced non-small-cell lung cancer.
    Hirose T; Horichi N; Ohmori T; Kusumoto S; Sugiyama T; Shirai T; Ozawa T; Ohnishi T; Adachi M
    Intern Med; 2005 Feb; 44(2):107-13. PubMed ID: 15750269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of Early Palliative Care With Chemotherapy Intensity in Patients With Advanced Stage Lung Cancer: A National Cohort Study.
    Lammers A; Slatore CG; Fromme EK; Vranas KC; Sullivan DR
    J Thorac Oncol; 2019 Feb; 14(2):176-183. PubMed ID: 30336324
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quality of Life Achieved by Carboplatin Plus Etoposide as Third-Line Chemotherapy Compared with Best Supportive Care in Non-Small Cell Lung Cancer Stage IIIB/IV.
    Maneechawakajorn J; Hathaisanguan S
    J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S175-81. PubMed ID: 27266233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patient-Centered Outcome Measures in Lung Cancer Trials.
    Schulkes KJ; Nguyen C; van den Bos F; Hamaker ME; van Elden LJ
    Lung; 2016 Aug; 194(4):647-52. PubMed ID: 27287676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Small cell lung cancer: pathophysiologic mechanisms and nursing implications.
    Glover J; Miaskowski C
    Oncol Nurs Forum; 1994; 21(1):87-95; quiz 96-7. PubMed ID: 8140007
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors and survival outcome for non-elective referral in non-small cell lung cancer patients--analysis based on the National Lung Cancer Audit.
    Beckett P; Tata LJ; Hubbard RB
    Lung Cancer; 2014 Mar; 83(3):396-400. PubMed ID: 24457105
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancer.
    Davidoff AJ; Gardner JF; Seal B; Edelman MJ
    J Thorac Oncol; 2011 May; 6(5):934-41. PubMed ID: 21372743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prior cancer does not adversely affect survival in locally advanced lung cancer: A national SEER-medicare analysis.
    Laccetti AL; Pruitt SL; Xuan L; Halm EA; Gerber DE
    Lung Cancer; 2016 Aug; 98():106-113. PubMed ID: 27393515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of change in symptoms, respiratory status, nutritional profile and quality of life on response to treatment for advanced non-small cell lung cancer.
    Mohan A; Singh P; Kumar S; Mohan C; Pathak AK; Pandey RM; Guleria R
    Asian Pac J Cancer Prev; 2008; 9(4):557-62. PubMed ID: 19256738
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non-Small Cell Lung Cancer in the U.S. National Cancer Data Base.
    Osarogiagbon RU; Lin CC; Smeltzer MP; Jemal A
    J Thorac Oncol; 2016 Jan; 11(1):e5-16. PubMed ID: 26762752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Socioeconomic position and surgery for early-stage non-small-cell lung cancer: A population-based study in Denmark.
    Kærgaard Starr L; Osler M; Steding-Jessen M; Lidegaard Frederiksen B; Jakobsen E; Østerlind K; Schüz J; Johansen C; Oksbjerg Dalton S
    Lung Cancer; 2013 Mar; 79(3):262-9. PubMed ID: 23276505
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.
    Takayama K; Atagi S; Imamura F; Tanaka H; Minato K; Harada T; Katakami N; Yokoyama T; Yoshimori K; Takiguchi Y; Hataji O; Takeda Y; Aoe K; Kim YH; Yokota S; Tabeta H; Tomii K; Ohashi Y; Eguchi K; Watanabe K
    Support Care Cancer; 2016 Aug; 24(8):3473-80. PubMed ID: 27003901
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Survival associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small-cell lung cancer.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    Int J Chron Obstruct Pulmon Dis; 2019; 14():893-903. PubMed ID: 31118599
    [No Abstract]   [Full Text] [Related]  

  • 56. Sex-Dependent Staging in Non-Small-Cell Lung Cancer; Analysis of the Effect of Sex Differences in the Eighth Edition of the Tumor, Node, Metastases Staging System.
    Wainer Z; Wright GM; Gough K; Daniels MG; Russell PA; Choong P; Conron M; Ball D; Solomon B
    Clin Lung Cancer; 2018 Nov; 19(6):e933-e944. PubMed ID: 30206043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Locally advanced non-small cell lung cancer: do we know the questions? A survey of randomized trials from 1966-1993.
    Brundage MD; Mackillop WJ
    J Clin Epidemiol; 1996 Feb; 49(2):183-92. PubMed ID: 8606319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapy.
    Thongprasert S; Sanguanmitra P; Juthapan W; Clinch J
    Lung Cancer; 1999 Apr; 24(1):17-24. PubMed ID: 10403690
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can early palliative care with anticancer treatment improve overall survival and patient-related outcomes in advanced lung cancer patients? A review of the literature.
    Ambroggi M; Biasini C; Toscani I; Orlandi E; Berte R; Mazzari M; Cavanna L
    Support Care Cancer; 2018 Sep; 26(9):2945-2953. PubMed ID: 29704108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.